Volume 12, Issue 1 (2026)                   Pharm Biomed Res 2026, 12(1): 9-26 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Anis A, Das A, Das Kirtania M, Das L, Roy Biswas G. Gastro-retentive Drug Delivery Systems Based on Pectin: An Overview. Pharm Biomed Res 2026; 12 (1) :9-26
URL: http://pbr.mazums.ac.ir/article-1-722-en.html
1- School of Pharmacy, Techno India University, Kolkata, India.
2- BCDA College of Pharmacy and Technology, Kolkata, India.
Abstract:   (157 Views)
Background: Controlled drug delivery systems (DDS) are designed to release therapeutic agents in a regulated manner to maintain consistent plasma drug concentrations. Among these systems, gastro-retentive DDS (GRDDS) have gained considerable attention due to their ability to prolong gastric residence time, thereby enhancing drug bioavailability and therapeutic efficacy for drugs absorbed primarily in the stomach or upper gastrointestinal tract.
Objectives: This review aimed to critically examine the role of pectin-based polymers in the development of GRDDS, with particular emphasis on formulation strategies using high- and low-methoxylated pectins.
Results: Pectin, a naturally derived polysaccharide, is widely utilized in pharmaceutical formulations owing to its biocompatibility, biodegradability, non-toxic nature, and excellent gel-forming capacity. Based on its degree of methoxylation (DM), pectin is classified into high-methoxylated and low-methoxylated forms, each exhibiting distinct physicochemical and functional properties. Low-methoxylated pectin has been extensively explored in floating DDS due to its calcium-dependent gelation behavior. In contrast, high-methoxylated pectin demonstrates strong mucoadhesive properties, making it suitable for mucoadhesive gastro-retentive formulations. Comparative studies with other natural polymers highlight the versatility of pectin in GRDDS design.
Conclusion: Pectin-based gastro-retentive formulations represent a promising and sustainable approach for controlled drug delivery. Understanding the distinct characteristics of high- and low-methoxylated pectin enables the rational design of effective GRDDS, potentially improving therapeutic outcomes and patient compliance.
Full-Text [PDF 1541 kb]   (76 Downloads)    
Type of Study: Review article | Subject: Natural products

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb